NEO NASDAQ
NeoGenomics, Inc.
1W: +1.6%
1M: -13.7%
3M: +24.6%
YTD: +41.9%
1Y: +59.7%
3Y: +21.2%
5Y: -61.8%
$17.27
+0.58 (+3.48%)
After Hours: $17.18 (-0.09, -0.55%)
Weekly Expected Move ±8.8%
$14
$15
$17
$18
$20
Credit Risk of going bust: higher than 52% of companies Debt: 17.1% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.31 (down 98%), NeoGenomics, Inc. would be worth roughly what it owes.
Total debt $448.4M against a stock market value of $2.17B.
Distance to default 4.94 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $192.5M (short-term plus half of long-term), stock volatility 53.3%; Altman Z'' 1.45. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.31 (down 98%), NeoGenomics, Inc. would be worth roughly what it owes.
Total debt $448.4M against a stock market value of $2.17B.
Distance to default 4.94 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $192.5M (short-term plus half of long-term), stock volatility 53.3%; Altman Z'' 1.45. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
2 relationships2
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2021-05-05
Earliest Filing
2021-06-24
Latest Filing
target: 2
Counterparties (Filed by NEO)
2 relationshipsCompanies named in NEO's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Inivata Limited | — | target | Acquired by NeoGenomics Laboratories for $390 million in cash. | 2021-06-24 | View |
| Inivata Limited | — | target | Target company acquired by NeoGenomics Laboratories in a share purchase agreement for $390 million. | 2021-05-05 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-05 | Earnings Release; Officer/Director Change; Bylaws Amendment; Exhibits | View | |
| 2026-08-11 | Officer/Director Change | View | |
| 2026-07-28 | Earnings Release; Exhibits | View | |
| 2026-07-22 | Regulation FD; Other Events; Exhibits | View | |
| 2026-07-20 | Regulation FD; Other Events; Exhibits | View | |
| 2026-06-25 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-06-22 | Material Agreement; Financial Obligation; Unregistered Equity Sales; Other Events; Exhibits | Agreement | View |
| 2026-06-17 | Other Events; Exhibits | View | |
| 2026-06-15 | Other Events; Exhibits | View | |
| 2026-05-22 | Officer/Director Change; Shareholder Vote; Exhibits | View | |
| 2026-04-28 | Earnings Release; Exhibits | View | |
| 2026-02-17 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-01-12 | Results of Operations and Financial Condition; Departure/Election of Directors; Appointment of Offic | View | |
| 2025-12-30 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-10-28 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-08 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-07-29 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-06-24 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-05-27 | Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit | View | |
| 2025-04-29 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR